SRGA VS SINT Stock Comparison

PerformanceTechnicalsEarningsProfitVolatility
PerformanceTechnicalsEarningsProfitVolatility

Performance

SRGA
10/100

SRGA returned -94.30% in the last 12 months. Based on SPY's performance of -3.90%, its performance is below average giving it a score of 10 of 100.

SINT
10/100

SINT returned -95.55% in the last 12 months. Based on SPY's performance of -12.08%, its performance is below average giving it a score of 10 of 100.

Technicals

SRGA
14/100

SRGA receives a 14 of 100 based on 14 indicators. 2 are bullish, 12 are bearish.

SINT
43/100

SINT receives a 42 of 100 based on 14 indicators. 5 are bullish, 7 are bearish.

Earnings

SRGA
44/100

SRGA has missed earnings 3 times in the last 20 quarters.

SINT
10/100

SINT has missed earnings 12 times in the last 20 quarters.

Profit

SRGA
35/100

Out of the last 20 quarters, SRGA has had 7 profitable quarters and has increased their profits year over year on 5 of them.

SINT
10/100

Out of the last 20 quarters, SINT has had 1 profitable quarters and has increased their profits year over year on 1 of them.

Volatility

SRGA
57/100

SRGA has had a higher than average amount of volatility over the last 12 months giving it a score of 57 of 100.

SINT
50/100

SINT has had an average amount of volatility over the last 12 months giving it a score of 50 of 100.

All score calculations are broken down here to help you make more informed investing decisions

Surgalign Holdings, Inc. Common Stock Summary

Nasdaq / SRGA
Healthcare
Medical Devices
Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine. The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2.0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; and SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability. In addition, it develops Augmented Reality and Artificial Intelligence digital surgery platform to enable digital spine surgery. The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois.

SiNtx Technologies, Inc. Common Stock Summary

Nasdaq / SINT
Healthcare
Medical - Devices
Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.